ClinicalTrials.Veeva

Menu

Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss

University of Washington logo

University of Washington

Status

Not yet enrolling

Conditions

Hearing Loss
Hearing Loss, Sensorineural

Treatments

Device: Oticon Real Hearing Aid
Device: Phonak Infineo Hearing Aid
Device: Artificial Intelligence Integrated Hearing Aid Use

Study type

Interventional

Funder types

Other

Identifiers

NCT06792110
STUDY00018443

Details and patient eligibility

About

The goal of this clinical trial will be to evaluate the efficacy of artificial intelligence-integrated hearing aids in individuals with hearing loss. The main questions to answer are:

  1. How effective is an artificial intelligence integrated hearing aid in improving speech perception in noise.
  2. How does an artificial intelligence integrated hearing aid compare to currently available commercial hearing aids.

Full description

Hearing loss is a leading cause of disability globally. Undertreated hearing loss has been associated with several deleterious sequelae, including social isolation, decreased quality of life, and cognitive decline. For a large portion of individuals with hearing loss, hearing aids remain the intervention of choice for improving communication, decreasing social isolation, and enhancing quality of life. Yet, less than 20% of hearing aid candidates choose to use them2. This is partly due to a perceived lack of benefit from hearing aids. Individuals who use hearing aids continue to report difficulty with speech perception in noisy environments with multiple speakers, such as parties, restaurants, and other complex auditory settings.

The investigators have developed a neural network that runs on-device to achieve real-time target speech hearing in realistic multi-talker environments. Using our neural network, the wearer can focus on speech from a target speaker by learning their unique speech cues while ignoring all interfering speech and noise in complex acoustic environments. The wearer is additionally able to use distance to separate sounds from the environment from target sounds to be amplified. Finally the wearer is also able to specificy categories of sound that will be amplified in environment.

This study will prospectively study a hearing aid implementing these algorithms on individuals with hearing loss. Participants will be randomized to utilizing one of two commercial hearing aids vs the experimental device. Participants will participate in listening tests in which they must identify the words spoken by a specific voice in multi-talker babble noise. The investigators will measure performance with the primary and secondary outcome measures listed elsewhere.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Minimum Age of 18 yo
  • Bilateral sensorineural hearing loss amenable to hearing aids
  • Able to give informed consent
  • Native English speaker
  • Able to wear a standard pair of hearing aids

Exclusion criteria

  • Unable to participate in informed consent
  • Use of a cochlear implant
  • Hearing loss not amenable to hearing aid use
  • Conductive hearing loss

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Oticon Hearing Aid vs Experimental Hearing Aid
Experimental group
Description:
Participants will use both one hearing aid model that is commercial and the experimental hearing aid on listening tasks.
Treatment:
Device: Artificial Intelligence Integrated Hearing Aid Use
Device: Phonak Infineo Hearing Aid
Phonak Hearing Aid vs Experimental Hearing Aids
Experimental group
Description:
Participants will use both one hearing aid model that is commercial and the experimental hearing aid on listening tasks.
Treatment:
Device: Artificial Intelligence Integrated Hearing Aid Use
Device: Oticon Real Hearing Aid

Trial contacts and locations

0

Loading...

Central trial contact

Arun Raghavan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems